Contraceptives are birth controlling products used to avoid unplanned pregnancy. Contraceptive methods that are commonly used include hormonal method, sterilization, intrauterine method, emergency contraception, and barrier method. Sterilization is most common method that is used all over the world. According to United Nations statistics 2015, in regions like North America, sterilization is a dominant contraceptive method used for birth spacing. Some advanced contraceptive methods include vaginal rings, implants, Intra-uterine devices (IUDs), injectable, patches, and combined oral contraceptives.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/368
There are many contraceptives for women available in the market, yet, some of the University scientists and companies are trying to develop contraceptive methods for males. Launch of these novel male contraceptive product with higher efficiency are expected to drive growth of the contraceptive drugs and devices market in the U.S. during the forecast period.
The U.S. still has untapped market of contraceptives drugs and devices that competitors can address. According the 2015 estimates of the UN, North America has 7% of unmet needs for contraceptives in the region.
The U.S. contraceptive drugs and devices market was valued at US$ 6,785.9 million in 2016 and is expected to expand at a CAGR of 5.6% during the forecast period (2016 – 2024)
Growing use of contraceptives in low and middle-income populace and favourable reimbursement policies are expected to boost growth of the U.S. contraceptives drugs and devices market. For instance, Long-acting reversible contraceptives (LARC) are covered in the insurance as employed by the U.S. Affordable Care Act. The new policy announced by State covers health and reproductive products as well as medically essential abortion services for the people in U.S. providing relief to general public where 45% of pregnancies are unintended as reported by the 2009-2013 study data of CDC.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/368
Restrictions in Medicaid coverage in some parts of the U.S. is increasing the demand for particular contraceptives in the region, which is expected to propel growth of the U.S. contraceptive drugs and devices market. For instance, Insurance coverage for contraceptive devices is different in each state of the U.S. Idaho, Alabama and South California do not include contraceptive pills in the Medicaid programs, while dispensing of injectable contraceptives is allowed in California by clinics.
Increasing awareness among consumers and growing availability of new contraceptive methods over contraceptive pills is creating the demand for contraceptive products, which in turn is expected to drive growth of the U.S. contraceptive drugs and devices market over the forecast period. For instance, in 2015, the United Nations reported that 9 out 10 married or in-union women prefer modern contraceptive methods. Moreover, due to their higher efficiency compared to traditional contraceptives like oral hormonal pills, sexologists and gynaecologists now recommend using long-acting reversible contraceptives for people who don’t plan to have a child in coming future.
Factors such as no-cost coverage insurance policies for sterilization is expected to restrict growth of the U.S. contraceptive drugs and devices market.
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/368
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 U.S. Contraceptives Drugs And Devices Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: U.S. Contraceptives Drugs And Devices Industry Impact
Chapter 2 U.S. Contraceptives Drugs And Devices Competition by Types, Applications, and Top Regions and Countries
2.1 U.S. Contraceptives Drugs And Devices (Volume and Value) by Type
2.3 U.S. Contraceptives Drugs And Devices (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 U.S. Contraceptives Drugs And Devices Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 U.S. Contraceptives Drugs And Devices Market Analysis
Chapter 6 Company Profiles and Key Figures in U.S. Contraceptives Drugs And Devices Business
Chapter 7 U.S. Contraceptives Drugs And Devices Market Forecast (2021-2027)
Chapter 9 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027